Evidence map›Paper›PMID 40563594›Full record

ArticleCancers2025

Therapeutic Consequences of

Friederike Eilsberger, Ali Ebrahimifard, Florian Torsten Spiegel, Behrooz Hooshyar Yousefi, Shamim Bagheri, Wadim Bowl, Qi Wang, Andreas Pfestroff, Laura Müller, Markus Luster and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Friederike EilsbergerDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.ORCID 0000-0003-3558-6817
Ali EbrahimifardDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.ORCID 0009-0009-4123-2928
Florian Torsten SpiegelDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.
Behrooz Hooshyar YousefiDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.ORCID 0000-0003-0679-4449
Shamim BagheriDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.
Wadim BowlDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.
Qi WangDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.
Andreas PfestroffDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.
Laura MüllerDepartment of Urology, University Hospital Marburg, Philipps University Marburg, 35037 Marburg, Germany.
Markus LusterDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.
Pietro Di FazioDepartment of Nuclear Medicine, University Hospital Marburg, Philipps University Marburg, 35043 Marburg, Germany.ORCID 0000-0003-0091-8498
Damiano LibrizziDepartment of Nuclear Medicine, Protestant Hospital of Bethel Foundation, 33611 Bielefeld, Germany.

Funding

Philipps University of Marburg Clinician Scientist Program
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

D’AmicoGleason scorePET/CTprostate cancerPSAPSMArisk group

Identifiers

PMID40563594
PMCPMC12190812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.